Introduction Semaglutide Is rapidly emerging as a revolutionary medication in the treatment of type 2 diabetes, obesity, and related cardiovascular conditions. Initially designed to improve blood sugar control in people with type 2 diabetes, Semaglutide is a part of the GLP-1 (glucagon-like peptide-1) receptor agonists class of drugs. This class https://emilianofzsjz.smblogsites.com/31557674/semaglutide-a-breakthrough-in-managing-type-2-diabetes-obesity-and-heart-health